Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Baby teeth stem cells can potentially grow organs and treat diseases.

Papulopustular rosacea is an inflammatory skin condition treatable with lifestyle changes and medications.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Hair and nails can help diagnose diseases, with nail issues often linked to skin conditions and hair loss having various causes and treatments.

Different hair and nail conditions can indicate health issues and have specific treatments; accurate diagnosis is crucial before treatment.

Dermoscopy is a useful tool for identifying features of skin conditions, but more research is needed to define its role in dermatology.

Trichoscopy is a quick, noninvasive method to diagnose hair and scalp disorders, often reducing the need for biopsies.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Examining scalp biopsies in different ways helps better diagnose hair loss types.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

People with Alopecia Areata often have thyroid problems like Hashimoto thyroiditis and hypothyroidism.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.